SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

18 Jul 2016 Evaluate

Dr Reddys Laboratories has informed about a Press Release dated July 18, 2016 titled ‘Dr. Reddys Laboratories announces the launch of Omeprazole and Sodium bicarbonate capsules in the US Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1287.65 -5.60 (-0.43%)
11-May-2026 11:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.25
Dr. Reddys Lab 1287.65
Cipla 1335.20
Zydus Lifesciences 946.45
Lupin 2242.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×